Natural killer cells determine the outcome of B cell-mediated autoimmunity

Nature Immunology

Volumn 1, Issue 3, 2000, Pages 245-251

  Shi, Fu Dong ^a,e   Wang, Hua Bing ^b   Li, Hulun ^b   Hong, Seokmann ^c   Taniguchi, Masaru ^d   Link, Hans ^b   Van Kaer, Luc ^c   Ljunggren, Hans Gustaf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHIBA UNIVERSITY   (Japan)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GAMMA INTERFERON; INTERLEUKIN 8; NICOTINIC RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BIOSYNTHESIS; C57BL MOUSE; FEMALE; GENETICS; IMMUNIZATION; IMMUNOLOGY; INBREEDING; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; MOUSE; MYASTHENIA GRAVIS; NATURAL KILLER CELL; T LYMPHOCYTE; TORPEDO;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; FEMALE; IMMUNIZATION; INBREEDING; INTERFERON TYPE II; INTERLEUKIN-8; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; RECEPTORS, NICOTINIC; T-LYMPHOCYTES; TORPEDO; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034280106     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/79792     Document Type: Article

References (39)

1. Tak, P. P. et al. Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum. 37, 1735-1743 (1994).
2. Dalakas, M. C. & Illa. I. Common variable immunodeficiency and inclusion body myositis: a distinct myopathy mediated by natural killer cells. Ann. Neurol. 37, 806-810 (1995).
3. Garcia-Suarez, J. et al. Persistent lymphocytosis of natural killer cells in autoimmune thrombocytopenic purpura (ATP) patients after splenectomy. Br. J. Haemat. 89, 653-655 (1995).
4. Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M. & Tabira, T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186, 1677-1687 (1997).
5. Matsumoto, Y. et al. Role of natural killer cells and TCRγδ T cells in acute autoimmune encephalomyelitis. Eur. J. Immunol. 28, 1681-1688 (1998).
6. + T cells in a transfer model of colitis. J. Immunol. 161, 3256-3261 (1998).
7. α281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188, 1831-1839 (1998).
8. Litzenburger, T. et al. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J. Exp. Med. 188, 169-180 (1998).
9. Drachman, D. B. Myasthenia gravis. N. Engl. J. Med. 330, 1797-1810 (1994).
10. Berman, P.W. & Patrick, J. Experimental myasthenia gravis: a murine system. J. Exp. Med. 151, 204-223 (1980).
11. Balasa B. et al. Interferon γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental myasthenia gravis in mice. J. Exp. Med. 186, 385-391 (1997).
12. Moiola, L et al. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody mediated disease. Eur. J. Immunol. 28, 2487-2497 (1998).
13. Shi, F.-D. et al. Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis. Eur. J. Immunol. 28, 3587-3593 (1998).
14. α14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623-1626 (1997).
15. Mendiratta, S.K. et al. CDldl mutant mice are deficient in natural T cells chat promptly produce IL-4. Immunity 6, 469-477 (1997).
16. Mason, D. & Powrie, F. Control of immune pathology by regulatory T cells. Curr. Opin. Immunol. 10, 649-655 (1998).
17. + T cells. J. Exp. Med. 188, 1849-1857 (1998).
18. Okamura, H. et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378, 88-91 (1995).
19. Takeda, K. et al. Defective NK cell activity and Th1 responses in IL-18-deficient mice, Immunity 8, 383-390 (1998).
20. Romagnani, S. Induction of TH1 and TH2 responses: a key role for the "natural" immune responses? Immunol. Today. 13, 379-311 (1992).
21. Douglas, T. F. The instructive role of innate immunity in the acquired immune response. Science 272, 50-54 (1996).
22. Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869-877 (1992).
23. Dalton, D.K. et al. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259, 1739-1745 (1993).
24. Shi, F.-D. et al. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: Identification of regulatory cells. J. Immunol. 162, 5757-5763 (1999).
25. + T and NK cells. J. Exp. Med. 180, 1937-1942 (1994).
26. + T cells, IL-2, and NK cell-derived TGF-β: Contrasting effects of anti-CD2 and anti-CD3. J. Immunol. 160, 2248-2254 (1998).
27. Yuan, D., Koh, C.Y. & Wilder, J.A. Interactions between B lymphocytes and NK cells. FASEB J. 8, 1012-1018 (1994).
28. Seaman, W. E., Sleisenger, M., Eriksson, E. & Koo, G. C. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1: Reduction in host defense against malignancy without loss of cellular or humoral immunity. J. Immunol. 138, 4539-4544 (1987).
29. Snapper, C. M. & Mond, J. J. Towards a comprehensive view of immunoglobulin class switching, Immunol. Today 14, 15-18 (1993).
30. Ridderstad, A., Lettesjö, H., Abedi-Valugerdi, M. & Möller, E. Differential sensitivity to transforming growth factor (TGF)-β of CBA and of CBA/N B cells demonstrates that the IgG2b inducing factor in synovial fluid from rheumatoid arthritis patients is not identical toTGF-β. Int. Immunol. 7, 459-469 (1995).
31. Hong, S. et al. Lipid antigen presentation in the immune system: lessons learned from CDId knockout mice. Immunol. Rev. 169, 31-44 (1999).
32. Rauch, H. C., Montgometry, I. N. & Kaplan, J. Natural killer cell activity in multiple sclerosis and myasthenia gravis. Immunol. Invest. 14, 427-434 (1985).
33. Vranes, Z., Poljakovic, Z. & Marusic, M. Natural killer cell number and activity in multiple sclerosis. J. Neurol. Sci. 94, 115-123 (1989).
34. Lindstrom J., Einarson, B. & Tzartos, S. Production and assay of antibodies to AChR. Methods Enzymol. 74, 432-460 (1981).
35. Deibler, G. E., Martensson, R. E. & Kies, M.W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2, 139-164 (1972).
36. Koo, G. C. & Peppard J. R. Establishment of monoclonal anti-NKI.1 antibody. Hybridoma 3, 301-303 (1984).
37. Dasch, J. R., Pace, D. R., Waegell, W., Ineaga, D. & Ellingsworth, L Monoclonal antibodies recognizing transforming growth factor-β. Bioactivity neutralization and transforming growth factor-β2 affinity purification. J. Immunol. 142, 1536-1541 (1989).
38. Chambers, B. J., Salcedo, M. & Ljunggren, H. G. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-I). Immunity 5, 311-317 (1996).
39. Korsgren, M. et al. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J. Exp. Med. 189, 553-562 (1999).